What other stocks do shareholders of (VTAE) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (VTAE) investors own include Bausch Health Companies (BHC) , Mallinckrodt (MNK) , Zosano Pharma (ZSAN) , Akari Therapeutics (AKTX) , Aquinox Pharmaceuticals (AQXP) , Sangamo Therapeutics (SGMO) , Trevena (TRVN) and Arbutus Biopharma (ABUS) .

NASDAQ:VTAE

(VTAE) (VTAE) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free VTAE Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $21.00
▼
$21.00
50-Day Range: N/A
52-Week Range: $4.08
▼
$21.03

Volume: N/A
Average Volume: 763,870 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (VTAE) alerts:

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

About (VTAE) Stock (NASDAQ:VTAE)

Vitae Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on discovering and developing small molecule drugs for diseases. It is engaged in developing a portfolio of product candidates through Contour, its structure-based drug discovery platform. The Company's product candidates include VTP- 43742 for the treatment of psoriasis, as well as multiple other autoimmune disorders. The Company completed approximately two Phase I studies with VTP-43742. Its VTP-38543, a second product candidate is in a Phase IIa proof-of-concept clinical trial for the treatment of atopic dermatitis. Its VTP-36951 is for the treatment and prevention of Alzheimer's disease, or Alzheimer's. VTP-43742, the Company's wholly owned clinical candidate in an on-going Phase IIa proof-of-concept trial in psoriasis, is an orally active small molecule inhibitor of Retinoic acid-receptor (RAR)-Related Orphan Receptor gamma-t (RORgt) activity for the treatment of various autoimmune disorders.

Ad Paradigm Press

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

Click here to find out that this 8,788% cryptocurrency is.

VTAE Stock News Headlines

November 27, 2023 | msn.com

Michigan, Washington move up in top five of US LBM Coaches Poll, while Ohio State tumbles

June 9, 2023 | msn.com

Georgia tax revenue falls nearly 8% in May, officials say

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 5, 2023 | msn.com

Canada can play a big role in addressing growing food insecurity, Nutrien CEO says

February 26, 2023 | msn.com

Turkey rocked by another quake — the third in 2 weeks

January 3, 2023 | msn.com

"Maybe" - Sky Sports man hints at "minutes" for Arsenal talent in FA Cup

December 21, 2022 | msn.com

How private business jet subscriptions are changing luxury travel – VistaJet and Jettly mean holidaying like a celebrity with no waiting, Michelin-star food and only 24 hours ...

December 5, 2022 | msn.com

Clayton Kershaw signs 1-year deal to return to Dodgers

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

November 9, 2022 | msn.com

Tropical Storm Nicole Closures, Cancellations In Sarasota, Bradenton

September 3, 2022 | thestreet.com

Vitae Pharmaceuticals (VTAE) Stock Skyrockets on Positive Trial Results

August 10, 2022 | msn.com

Independence Island and Bailey's Island are on the market: here's a brief history

August 10, 2022 | msn.com

‘Hell on earth’: Personal stories from UNT’s North Texas Heat Research Project

April 16, 2022 | nasdaq.com

Interesting CIEN Put And Call Options For June 17th

April 8, 2022 | investing.com

Vitae Pharmaceuticals Inc (VTAE)

March 10, 2022 | msn.com

‘They were shooting civilians’: Ukraine refugees saw abuses

January 22, 2022 | thestreet.com

Vitae Pharmaceuticals (VTAE) Stock Downgraded on $639 Million Allergan Deal

August 27, 2021 | dailymail.co.uk

Ashley Graham puts her baby bump on display in bright pink bikini as she enjoys family time

August 19, 2021 | msn.com

Northampton County district judge, former assistant prosecutor dies after bout with cancer. ‘A voice for the voiceless’

August 18, 2021 | msn.com

Northampton County district judge dies after long bout with cancer

See More Headlines

Receive VTAE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (VTAE) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:VTAE
CUSIP: N/A
CIK: 1157602
Web: ir.vitaepharma.com
Phone: +1-215-4612000
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

VTAE Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (VTAE) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (VTAE) investors own include Bausch Health Companies (BHC), Mallinckrodt (MNK), Zosano Pharma (ZSAN), Akari Therapeutics (AKTX), Aquinox Pharmaceuticals (AQXP), Sangamo Therapeutics (SGMO), Trevena (TRVN) and Arbutus Biopharma (ABUS).

This page (NASDAQ:VTAE) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(VTAE) (VTAE) Stock Price, News & Analysis

About (VTAE) Stock (NASDAQ:VTAE)

VTAE Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

VTAE Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info